What Has Been the Progress and Growth of the Knee Bursitis Market in Recent Years?
The knee bursitis market has seen considerable growth due to a variety of factors.
• The knee bursitis market has seen strong growth in recent years, expected to rise from $2.66 billion in 2024 to $2.86 billion in 2025, growing at a CAGR of 7.6%.
The primary reasons for this growth include an aging population, increased participation in physical activities and sports, better diagnostic techniques, improved access to healthcare, and educational programs aimed at both healthcare professionals and patients.
How Does the Forecast Look for the Knee Bursitis Market?
The knee bursitis market is expected to maintain its strong growth trajectory in upcoming years.
• The knee bursitis market is expected to grow to $3.79 billion by 2029, with a CAGR of 7.3%.
Factors contributing to growth include increased awareness campaigns, rising healthcare expenditures, better diagnosis, and awareness of knee bursitis. Major trends include advancements in diagnostic techniques, the development of new therapies, and the rise of telemedicine and remote monitoring.
What Are The Leading Drivers Of Growth In The Knee Bursitis Market?
The increasing prevalence of bone-related diseases is expected to contribute to the growth of the knee bursitis market. Conditions like osteoporosis and arthritis, common in aging populations, can lead to knee bursitis due to joint wear and inflammation. Healthy Bones Australia projected that in 2022, 6.2 million Australians aged 50 and above had osteoporosis or osteopenia, further driving the knee bursitis market as these conditions contribute to increased cases of knee bursitis.
How Are The Segments Defined Within The Global Knee Bursitis Market?
The knee bursitis market covered in this report is segmented –
1) By Diagnosis: Imaging Test, Other Diagnosis Tests
2) By Treatment: Medication, Therapy, Surgery, Other Treatments
3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users
Subsegments:
1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound
2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests
Pre-Book The Knee Bursitis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Knee Bursitis Market?
Major companies operating in the knee bursitis market are:
• Pfizer Inc.
• Merck & Co. Inc
• Bayer AG
• Novartis AG
• Roche Holding AG
• Medtronic plc
• Eli Lilly and Company
• Amgen Inc
• Gilead Sciences Inc.
• Stryker Corporation
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Incorporated
• Zimmer Biomet Holdings Inc.
• DePuy Synthes Inc.
• Arthrex Inc.
• Globus Medical Inc.
• Bioventus LLC
• Exactech Inc.
• Genentech Inc.
• Conformis Inc.
• Oncolys BioPharma Inc
• Bellicum Pharmaceuticals Inc
• Merrimack Pharmaceuticals Inc
• 4Med Medical Solutions Inc
What Is The Most Dominant Region In The Knee Bursitis Market?
North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
